TY  - GEN
AU  - Sobocinski,Jonathan
AU  - Maurel,Blandine
AU  - Delsart,Pascal
AU  - d'Elia,Piervito
AU  - Guillou,Matthieu
AU  - Maioli,Filippo
AU  - Perot,Céline
AU  - Bianchini,Aurélia
AU  - Azzaoui,Richard
AU  - Mounier-Vehier,Claire
AU  - Haulon,Stéphan
TI  - Should we modify our indications after the EVAR-2 trial conclusions?
SN  - 1615-5947
PY  - 2011///1031
KW  - Aged
KW  - Aged, 80 and over
KW  - Aortic Aneurysm, Abdominal
KW  - diagnostic imaging
KW  - Aortography
KW  - methods
KW  - Blood Vessel Prosthesis Implantation
KW  - adverse effects
KW  - Chi-Square Distribution
KW  - Endovascular Procedures
KW  - Evidence-Based Medicine
KW  - France
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - therapeutic use
KW  - Kaplan-Meier Estimate
KW  - Patient Selection
KW  - Platelet Aggregation Inhibitors
KW  - Randomized Controlled Trials as Topic
KW  - Reoperation
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Risk Factors
KW  - Survival Rate
KW  - Time Factors
KW  - Tomography, X-Ray Computed
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1016/j.avsg.2010.08.010
ER  -